Moreover, treatment with a chymase inhibitor has been shown to alleviate colonic inflammation in DSS-induced colitis in mice (Andoh et al., 2006; Stasikowska-Kanicka et al., 2012; Liu et al., 2016), indicating that chymase may play a critical role in the pathogenesis of colitis. Here, CMA1 is linked to colitis.